Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10211615 | 0.88 | EPHX2 (0.64) | EPHX2SIGMAR1 | |
| SCHEMBL10212124 | 0.82 | NPC1 (0.68) | EPHX2EPHX1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL17705940 | 0.82 | EPHX2 (0.75) | EPHX2EPHX1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL28554753 | 0.82 | EPHX2 (0.80) | EPHX2EPHX1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL3455859 | 0.81 | EPHX2 (0.83) | EPHX2EPHX1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL13169536 | 0.81 | EPHX2 (0.83) | EPHX2EPHX1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL22868443 | 0.80 | ALDH1A1 (0.55) | EPHX2EPHX1HPGDSMN1; SMN2 | |
| SCHEMBL28704280 | 0.79 | USP30 (0.63) | EPHX2EPHX1HPGDSMN1; SMN2MAOA | |
| SCHEMBL4180735 | 0.79 | EPHX2 (0.69) | EPHX2EPHX1SIGMAR1 | |
| SCHEMBL13176318 | 0.79 | HPGD (0.70) | SIGMAR1HPGDSMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021003084-A1 | P2X7R ANTAGONISTS | QIAN LIGANG (US) | 2021-01-07 | — | — | WO | disclosed |